Figure 3From: An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients Effects of not using (A) vs using (B) an erythropoiesis-stimulating agent–free interval on mean hemoglobin levels over time. Back to article page